Author: Fatemi HM Popovic-Todorovic B Donoso P Papanikolaou E Smitz J Devroey P
Publisher: Reproductive Healthcare Ltd
ISSN: 1472-6483
Source: Reproductive BioMedicine Online, Vol.17, Iss.3, 2008-09, pp. : 307-311
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
This prospective randomized controlled pilot study was conducted in a tertiary referral university hospital to evaluate whether the administration of letrozole in the luteal phase of stimulated IVF cycles, through a decrease in oestradiol, could alter the suppressed LH levels in the luteal phase. Following oocyte retrieval, six oocyte donors aged ≤ 36 years were randomized to receive either 5 mg letrozole (